SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Re is an internet-native marketplace for insurance capital. It connects eligible capital providers with fully collateralized reinsurance activity conducted through licensed insurance entities. Blockchain infrastructure makes collateral, reserves, and selected operating data verifiable onchain. RE is the governance token of the Re Protocol. It governs protocol upgrades, technical permissions, committee formation, reporting standards, incentive policy, and governance procedures. Underwriting, claims, pricing, reserve decisions, and regulated operations remain with qualified professionals and licensed entities.

RE is trending as traders react to its recent listings on major platforms and discuss its position in the insurance-focused decentralized infrastructure sector. Community members are actively debating the token's long-term utility versus its short-term price volatility while monitoring circulation levels and institutional interest.

Serve Robotics, Inc. engages in providing self-driving delivery. It designs, develops, and operates zero-emissions robots that serve people in public spaces, starting with food delivery. The company was founded by Ali Kashani, Dmitry Demeshchuk and MJ Burk Chun in 2017 and is headquartered in Redwood City, CA.

Serve Robotics Inc

Serve Robotics is drawing significant investor attention as the market shifts focus toward the 'Physical AI' and robotics buildout, with traders closely monitoring its high short interest and aggressive expansion into hospital logistics. The community remains deeply divided, balancing excitement over strong revenue growth and strategic partnerships with concerns regarding high cash burn and the volatility of its retail-heavy trading base.

Seagate Technology Holdings Plc operates as holding company that is engaged in the development, production, and distribution of data storage products and electronic data storage solutions. Its products include hard disk drives, solid state hybrid drives, solid state drives, peripheral component interconnect express cards, serial advanced technology attachment controllers, storage subsystems and computing solutions. The firm offers its products under the Backup Plus and Expansion product lines, and Maxtor and LaCie brands. The company was founded in 1978 and is headquartered in Fremont, CA.

Seagate Technology Holdings Plc

Seagate Technology is trending as investors aggressively re-rate physical AI infrastructure, with community discussion highlighting a perceived structural supercycle in data storage demand. The conversation is driven by ongoing debates over whether memory and hard-drive shortages signal a long-term bottleneck or a speculative bubble reminiscent of past market cycles.

Taiwan Semiconductor Manufacturing Co., Ltd. engages in the manufacture and sale of integrated circuits and wafer semiconductor devices. Its chips are used in personal computers and peripheral products, information applications, wired and wireless communications systems products, and automotive and industrial equipment including consumer electronics such as smartphones, digital television, game consoles, and digital cameras. The company was founded by Chung Mou Chang on February 21, 1987 and is headquartered in Hsinchu, Taiwan.

Taiwan Semiconductor Manufacturing - ADR

TSMC is seeing a surge in investor interest driven by its massive capital expenditure to address unrelenting demand for advanced AI chip fabrication, coupled with news of its potential to raise prices. The community remains focused on the company's critical role as the global foundry bottleneck, with ongoing discussions centered on its long-term pricing power and its strategic management of supply constraints.

DoorDash, Inc. engages in the design, development, and operation of a food delivery and logistics platform. It serves consumers in the United States, Canada, and Australia. The company was founded by Andy Fang, Tony Xu, Stanley Tang, and Evan Moore on January 12, 2013 and is headquartered in San Francisco, CA.

DoorDash Inc - Ordinary Shares - Class A

DoorDash is trending as investors weigh strong order growth and international expansion against a cautious profit outlook and margin pressure from ongoing infrastructure investment. Community discussion remains polarized, with some traders viewing the stock as a key growth play due to aggressive vertical scaling, while others highlight concerns over competitive saturation and long-term path to profitability.

Gitlawb is a decentralized code collaboration platform designed for AI agents and human developers. It provides a Git-compatible hosting layer where repositories are stored across IPFS, Filecoin, and Arweave, and peer connectivity is handled through libp2p rather than a central server.  Identity on Gitlawb is based on decentralized identifiers (DIDs) using Ed25519 keys. Access control and delegation between users and agents are expressed as UCAN (User Controlled Authorization Networks) capabilities, allowing scoped, revocable permissions to be granted without a central authority. Each identity carries an on-chain trust score derived from verified contributions.  The protocol is accessed through three main surfaces: a Rust node (gitlawb-node) that serves repositories over HTTP and libp2p, a command-line client (gl) that handles identity, repositories, issues, bounties, and UCAN delegation, and a git remote helper (git-remote-gitlawb) that allows standard Git clients to push and pull using gitlawb:// URLs.  Additional products in the ecosystem include MiroClaw, an on-chain prediction market; Gitlawb Spawn, an AI agent orchestration tool; OpenClaude, an open-source agent harness aligned with Playground and Spawn; and a developer playground for testing agent interactions against the protocol.

Gitlawb

Gitlawb is trending as investors highlight its position as a decentralized, AI-native infrastructure for autonomous agents, bolstered by news of a significant supply reduction plan and potential strategic industry partnerships. Community sentiment remains focused on the project's long-term utility and its role in an evolving AI-driven ecosystem.

SK Telecom Co., Ltd. engages in the provision of telecommunication and internet services. It operates through the following business divisions: Wireless Communication, Wired Communication, and Other. The Wireless Communication division deals with mobile phones, wireless data, information, and communication business. The Wired Communication division provides phone, high-speed Internet, data, and communication network rental services. The Other division includes product sales-type data broadcasting channel use business. The company was founded on March 29, 1984 and is headquartered in Seoul, South Korea.

SK Telecom Co Ltd - ADR

SK Telecom Co. Ltd.

SK Telecom is trending as investors capitalize on its significant equity stake in Anthropic, which represents a substantial portion of the company's valuation as the AI leader approaches a potential IPO. While the community is actively debating the impact of U.S. regulatory restrictions on Anthropic's models, many retail investors view SKM as a unique and undervalued proxy for direct exposure to AI growth alongside its stable telecom foundation.

United States Natural Gas Fund LP. - United States Natural Gas Fund

United States Natural Gas Fund, LP

United States Natural Gas Fund (UNG) is trending as traders weigh volatile winter weather impacts and potential supply disruptions against healthy inventory levels. The community is actively debating the impact of geopolitical developments on energy infrastructure, the reliability of current export demand, and whether recent price action represents a sustainable bottom or a temporary weather-driven spike.

CorMedix, Inc. is a pharmaceutical and medical device company, which engages in the development and commercialization of therapeutic products for the prevention and treatment of diseases and conditions. The company was founded by Antony E. Pfaffle on July 28, 2006 and is headquartered in Berkeley Heights, NJ.

CorMedix Inc

CorMedix is trending as investors focus on strong utilization of its catheter lock solution, DefenCath, and heightened anticipation for upcoming quarterly results, which many hope will provide clarity on post-TDAPA reimbursement and future revenue projections. The community remains actively divided, with ongoing debates centered on management's ability to drive share price growth, institutional institutional interest from major holders, and the potential impact of pending kidney-related legislation on the sector.

Oscar Health, Inc. is a healthcare insurance company, which serves its customers through a technology platform. It offers individual and family, small group and medicare advantage plans, and technology platform to others within the provider and payor space. The company was founded by Mario Tobias Schlosser, Kevin Nazemi, and Joshua Kushner on October 25, 2012 and is headquartered in New York, NY.

Oscar Health Inc - Ordinary Shares - Class A

Oscar Health is capturing significant investor attention following a robust first-quarter earnings report that featured a substantial earnings beat, revenue growth, and reaffirmed full-year guidance. Community sentiment is largely bullish, driven by strong membership scaling and improved operating margins, though some market participants remain cautious regarding the stock's recent vertical price run and its long-term path to profitability.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Rigel Announces Closing of Licensing Agreement for VEPPANU (vepdegestrant)

Rigel Announces Closing of Licensing Agreement for VEPPANU (vepdegestrant) Rigel Announces Closing of Licensing Agreement for VEPPANU (vepdegestrant) PR Newswire SOUTH SAN FRANCISCO, Calif., June 16, 2026 SOUTH SAN FRANCISCO, Calif., June 16, 2026 /PRNewswire/ -- Rigel Pharmaceuticals, Inc.(Nasdaq...

Rigel to Present at the Jefferies Global Healthcare Conference

Rigel to Present at the Jefferies Global Healthcare Conference Rigel to Present at the Jefferies Global Healthcare Conference PR Newswire SOUTH SAN FRANCISCO, Calif., May 27, 2026 SOUTH SAN FRANCISCO, Calif., May 27, 2026 /PRNewswire/ -- Rigel Pharmaceuticals, Inc. (Nasdaq: RIGL), a commercial...

Rigel Announces Oral and Poster Presentations at the 2026 ASCO Annual Meeting and EHA2026 Congress

Rigel Announces Oral and Poster Presentations at the 2026 ASCO Annual Meeting and EHA2026 Congress Rigel Announces Oral and Poster Presentations at the 2026 ASCO Annual Meeting and EHA2026 Congress PR Newswire SOUTH SAN FRANCISCO, Calif., May 21, 2026 Oral presentation at ASCO Annual Meeting to...

Rigel to Present at the 2026 RBC Capital Markets Global Healthcare Conference

Rigel to Present at the 2026 RBC Capital Markets Global Healthcare Conference Rigel to Present at the 2026 RBC Capital Markets Global Healthcare Conference PR Newswire SOUTH SAN FRANCISCO, Calif...

Rigel Pharmaceuticals Inks Breast Cancer Drug Deal With Arvinas, Pfizer

Rigel Pharmaceuticals stock jumps after signing a VEPPANU licensing deal with Arvinas and Pfizer following recent FDA approval.read more...

RIGL Stock Jumps 15%, Short Interest Surges To Record High – Why Is Retail Eyeing A Further 40% Upside?

Equity

Rigel Pharmaceuticals signed a global licensing deal with Arvinas and Pfizer for an advanced breast cancer treatment.

Rigel Pharma Signs Licensing Agreement With Arvinas And Pfizer For Veppanu

(RTTNews) - Rigel Pharmaceuticals, Inc. (RIGL) on Tuesday said it has entered into a global license agreement with Arvinas, Inc. (ARVN) and Pfizer Inc. (PFE) to develop, manufacture and commercialize beast cancer treatment Veppanu...

Rigel Enters Exclusive Global Licensing Agreement for VEPPANU (vepdegestrant), an oral PROTAC, for the Treatment of 2L+ ER+/HER2-, ESR1m Advanced or Metastatic Breast Cancer

Rigel Enters Exclusive Global Licensing Agreement for VEPPANU (vepdegestrant), an oral PROTAC, for the Treatment of 2L+ ER+/HER2-, ESR1m Advanced or Metastatic Breast Cancer Rigel Enters Exclusive...

Rigel Pharmaceuticals Q1 Earnings Call Highlights

Rigel Pharmaceuticals (NASDAQ:RIGL) reported first-quarter 2026 results that management said reflected continued year-over-year growth across its three-product portfolio, while reiterating full-year guidance and highlighting upcoming data milestones for its R289 program in lower-risk myelodysplastic...

Rigel Pharmaceuticals Inc. Profit Falls In Q1

(RTTNews) - Rigel Pharmaceuticals Inc. (RIGL) announced earnings for first quarter that Dropped, from last year...

Rigel Pharmaceuticals, Inc. operates as a clinical stage biotechnology company. It discovers and develops novel, targeted drugs in the therapeutic areas of immunology, oncology and immune oncology. The firm focuses on intracellular signalling pathways and related targets that are critical to disease mechanisms. The company's products include Tavalisse, Fostamatinib and R835. Rigel Pharmaceuticals was founded by Donald G. Payan, James M. Gower, Thomas A. Raffin, Garry P. Nolan and Ronald B. Garren on June 14, 1996 and is headquartered in South San Francisco, CA.

Rigel Pharmaceuticals

Neutral Sentiment

Hold rates steady

Cut 25 bps

Hike 25 bps

Fed decision day is here - Kevin Warsh chairs his first FOMC meeting with markets pricing a hold at 3.50%-3.75% but watching for a hawkish shift. Vote on what you expect to be decided today, then drop your prediction for the first rate cut or hike in the comments.

What do you expect the Fed to decide at its FOMC meeting today? 
 
Drop a comment with when you expect the first cut/hike to be.

RIGLRigel Pharmaceuticals

Fundamentals

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest RIGL News